Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2010 (2010), Article ID 761715, 8 pages
http://dx.doi.org/10.1155/2010/761715
Clinical Study

C-Reactive Protein and Gamma-Glutamyltransferase Concentrations in Relation to the Prevalence of Type 2 Diabetes Diagnosed by Glucose or HbA1c Criteria in Chinese Adults in Qingdao, China

1Department of Epidemiology and Health Statistics, Shandong University, Jinan 250012, China
2Department of Non-Communicable Disease Prevention, Qingdao Municipal Centre for Disease Control and Prevention, no. 175, Shandong Road, Qingdao 266071, China
3Department of Public Health, University of Helsinki, 00014 Helsinki, Finland
4Diabetes Unit, Department of Chronic Disease Prevention, National Institute for Health and Welfare, 00014 Helsinki, Finland
5Qingdao Endocrinology and Diabetes Hospital, 266071 Qingdao, China
6Hong Kong Institute of Diabetes and Obesity, Hong Kong, China

Received 13 August 2010; Revised 12 October 2010; Accepted 12 October 2010

Academic Editor: Giuseppe Paolisso

Copyright © 2010 J. Ren et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Yang, J. Lu, J. Weng et al., “Prevalence of diabetes among men and women in China,” The New England Journal of Medicine, vol. 362, no. 12, pp. 1090–1101, 2010. View at Publisher · View at Google Scholar
  2. W. G. Gao, Y. H. Dong, Z. C. Pang et al., “Increasing trend in the prevalence of Type 2 diabetes and pre-diabetes in the Chinese rural and urban population in Qingdao, China,” Diabetic Medicine, vol. 26, no. 12, pp. 1220–1229, 2009. View at Publisher · View at Google Scholar
  3. WHO/IDF Consultation, “Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia,” Report of a WHO/International Diabetes Federation Consultation, World Health Organization Document Production Services, Geneva, Switzerland, 2006. View at Google Scholar
  4. D. M. Nathan, B. Balkau, E. Bonora et al., “International expert committee report on the role of the A1C assay in the diagnosis of diabetes,” Diabetes Care, vol. 32, no. 7, pp. 1327–1334, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. M. B. Snijder, J. M. Dekker, M. Visser et al., “Prospective relation of C-reactive protein with type 2 diabetes: response to Han et al.,” Diabetes Care, vol. 26, no. 5, pp. 1656–1657, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. C. B. Kathryn, M. S. Neison, C. F. Sinney, D. Eward, T. H. Lam, and S. L. Karen, “C-reactive protein predicts the deterioration of glycemia in Chinese subjects with impaired glucose tolerance,” Diabetes Care, vol. 26, no. 8, pp. 2323–2328, 2003. View at Publisher · View at Google Scholar
  7. Y. Doi, Y. Kiyohara, M. Kubo et al., “Elevated C-reactive protein is a predictor of the development of diabetes in a general Japanese population: the Hisayama study,” Diabetes Care, vol. 28, no. 10, pp. 2497–2500, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. N. De Rekeneire, R. Peila, J. Ding et al., “Diabetes, hyperglycemia, and inflammation in older individuals: the health, aging and body composition study,” Diabetes Care, vol. 29, no. 8, pp. 1902–1908, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Thorand, J. Baumert, H. Kolb et al., “Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984–2002,” Diabetes Care, vol. 30, no. 4, pp. 854–860, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. D.-H. Lee, M.-H. Ha, J.-H. Kim et al., “Gamma-glutamyltransferase and diabetes—a 4 year follow-up study,” Diabetologia, vol. 46, no. 3, pp. 359–364, 2003. View at Google Scholar · View at Scopus
  11. C. Meisinger, H. Löwel, M. Heier, A. Schneider, and B. Thorand, “Serum γ-glutamyltransferase and risk of type 2 diabetes mellitus in men and women from the general population,” Journal of Internal Medicine, vol. 258, no. 6, pp. 527–535, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. P. André, B. Balkau, C. Born, M. A. Charles, and E. Eschwège, “Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort,” Diabetologia, vol. 49, no. 11, pp. 2599–2603, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Hoelzel, C. Weykamp, J. O. Jeppsson et al., “IFCC reference system for measurement of haemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study,” Clinical Chemistry, vol. 50, pp. 166–174, 2004. View at Google Scholar
  14. G. Bedogni, S. Bellentani, L. Miglioli et al., “The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population,” BMC Gastroenterology, vol. 6, Article ID 33, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. K. G. M. M. Alberti, P. Zimmet, and J. Shaw, “Metabolic syndrome—a new world-wide definition. A consensus statement from the International Diabetes Federation,” Diabetic Medicine, vol. 23, no. 5, pp. 469–480, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. X. Zhou, Z. Pang, W. Gao et al., “Performance of an A1C and fasting capillary blood glucose test for screening newly diagnosed diabetes and pre-diabetes defined by an oral glucose tolerance test in Qingdao, China,” Diabetes Care, vol. 33, no. 3, pp. 545–550, 2010. View at Publisher · View at Google Scholar
  17. A. Festa, R. D'Agostino Jr., G. Howard, L. Mykkänen, R. P. Tracy, and S. M. Haffner, “Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS),” Circulation, vol. 102, no. 1, pp. 42–47, 2000. View at Google Scholar · View at Scopus
  18. S. E. Kahn, B. Zinman, S. M. Haffner et al., “Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes,” Diabetes, vol. 55, no. 8, pp. 2357–2364, 2006. View at Publisher · View at Google Scholar
  19. L. K. Heilbronn, M. Noakes, and P. M. Clifton, “Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, no. 6, pp. 968–970, 2001. View at Google Scholar · View at Scopus
  20. B. Thorand, J. Baumert, A. Döring et al., “Sex differences in the relation of body composition to markers of inflammation,” Atherosclerosis, vol. 184, no. 1, pp. 216–224, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. A. R. Folsom, S. H. Golden, L. L. Boland, and M. Szklo, “Association of endogenous hormones with C-reactive protein, fibrinogen, and white blood count in post-menopausal women,” European Journal of Epidemiology, vol. 20, no. 12, pp. 1015–1022, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. E. L. Ding, Y. Song, V. S. Malik, and S. Liu, “Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis,” Journal of the American Medical Association, vol. 295, no. 11, pp. 1288–1299, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Marchesini, M. Brizi, G. Blanchi et al., “Nonalcoholic fatty liver disease: a feature of the metabolic syndrome,” Diabetes, vol. 50, no. 8, pp. 1844–1850, 2001. View at Google Scholar
  24. S. Chitturi, S. Abeygunasekera, G. C. Farrell et al., “NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome,” Hepatology, vol. 35, no. 2, pp. 373–379, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Song, W. Jia, Y. Yao et al., “Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed type 2 diabetes,” Clinical Science, vol. 112, no. 11-12, pp. 599–606, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. Y.-J. Lee, J.-K. Kim, J.-H. Lee, H.-R. Lee, D.-R. Kang, and J.-Y. Shim, “Association of serum γ-glutamyltransferase with C-reactive protein levels and white blood cell count in Korean adults,” Clinical Chemistry and Laboratory Medicine, vol. 46, no. 10, pp. 1410–1415, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. C.-H. Kim, J.-Y. Park, K.-U. Lee, J.-H. Kim, and H.-K. Kim, “Fatty liver is an independent risk factor for the development of type 2 diabetes in Korean adults,” Diabetic Medicine, vol. 25, no. 4, pp. 476–481, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Balkau, C. Lange, S. Vol, F. Fumeron, and F. Bonnet, “Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study,” BMC Gastroenterology, vol. 10, article 56, 2010. View at Publisher · View at Google Scholar
  29. P. André, B. Balkau, C. Born et al., “Hepatic markers and development of type 2 diabetes in middle aged men and women: a three-year follow-up study—the D.E.S.I.R. study (Data from an Epidemiological Study on the Insulin Resistance syndrome),” Diabetes and Metabolism, vol. 31, no. 6, pp. 542–550, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Fraser, M. Thinggaard, K. Christensen, and D. A. Lawlor, “Alanine aminotransferase,γ-glutamyltransferase (GGT) and all-cause mortality: results froma population-based Danish twins study alanine aminotransferase, GGT and mortality in elderly twins,” Liver International, vol. 29, no. 10, pp. 1494–1499, 2009. View at Publisher · View at Google Scholar
  31. W. G. Gao, Y. H. Dong, Z. C. Pang et al., “A simple Chinese risk score for undiagnosed diabetes,” Diabetic Medicine, vol. 27, no. 3, pp. 274–281, 2010. View at Publisher · View at Google Scholar